OM
Opaleye Management Portfolio holdings
AUM
$494M
This Quarter Return
+20.38%
1 Year Return
+68.17%
3 Year Return
+608.37%
5 Year Return
+807.76%
10 Year Return
+24,567.29%
AUM
$350M
AUM Growth
+$350M
(+12%)
Cap. Flow
-$18.2M
Cap. Flow
% of AUM
-5.21%
Top 10 Holdings %
Top 10 Hldgs %
66.13%
Holding
48
New
13
Increased
10
Reduced
7
Closed
10
Top Buys
| 1 |
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
|
$7.31M |
| 2 |
Ocular Therapeutix
OCUL
|
$7.23M |
| 3 |
Assertio
ASRT
|
$3.95M |
| 4 |
PTC Therapeutics
PTCT
|
$3.92M |
| 5 |
TG Therapeutics
TGTX
|
$3.89M |
Top Sells
| 1 |
ABLX
Ablynx NV American Depositary Shares
ABLX
|
$18M |
| 2 |
IMMU
Immunomedics Inc
IMMU
|
$14.5M |
| 3 |
BPMC
Blueprint Medicines
BPMC
|
$12.4M |
| 4 |
Axogen
AXGN
|
$9.31M |
| 5 |
CRISPR Therapeutics
CRSP
|
$6.6M |
Sector Composition
| 1 | Healthcare | 93.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Axogen
AXGN
$743M
| $62.6M | 17.9% | 1,715,000 -255,000 | -13% | -$9.31M |
|
|
BPMC
2
DELISTED
Blueprint Medicines
BPMC
| $55M | 15.73% | 600,000 -135,000 | -18% | -$12.4M |
|
|
LOXO
3
DELISTED
Loxo Oncology, Inc
LOXO
| $20.7M | 5.92% | 179,400 +3,100 | +2% | +$358K |
|
4
Codexis
CDXS
$246M
| $18.7M | 5.35% | 1,700,600 | – | – |
|
5
FibroGen
FGEN
$47.8M
| $16.6M | 4.76% | 360,000 | – | – |
|
|
SBBP
6
DELISTED
Strongbridge Biopharma plc.
SBBP
| $14.1M | 4.02% | 1,590,000 +340,000 | +27% | +$3.01M |
|
|
CORI
7
DELISTED
Corium International, Inc.
CORI
| $12.2M | 3.49% | 1,065,000 +5,000 | +0.5% | +$57.3K |
|
8
Agios Pharmaceuticals
AGIO
$2.19B
| $10.6M | 3.04% | 130,000 | – | – |
|
9
Fennec Pharmaceuticals
FENC
$247M
| $10.6M | 3.02% | 873,000 +26,100 | +3% | +$316K |
|
10
Sangamo Therapeutics
SGMO
$157M
| $10.2M | 2.91% | 535,000 -45,000 | -8% | -$855K |
|
|
CBAY
11
DELISTED
Cymabay Therapeutics
CBAY
| $8.64M | 2.47% | 665,000 | – | – |
|
|
DCPH
12
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $7.31M | 2.09% | +365,000 | New | +$7.31M |
|
|
13
Ocular Therapeutix
OCUL
$2.12B
| $7.23M | 2.07% | +1,111,000 | New | +$7.23M |
|
14
Xoma
XOMA
$392M
| $6.48M | 1.85% | 320,200 | – | – |
|
15
Ardelyx
ARDX
$1.53B
| $5.73M | 1.64% | 1,135,600 +235,600 | +26% | +$1.19M |
|
|
BOLD
16
DELISTED
Audentes Therapeutics, Inc
BOLD
| $5.71M | 1.63% | 190,000 -20,000 | -10% | -$601K |
|
|
AMRN
17
Amarin Corp
AMRN
$311M
| $5.25M | 1.5% | 1,745,000 +885,000 | +103% | +$2.66M |
|
|
ABLX
18
DELISTED
Ablynx NV American Depositary Shares
ABLX
| $4.91M | 1.4% | 90,000 -330,000 | -79% | -$18M |
|
|
FOMX
19
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $4.87M | 1.39% | 950,000 -10,000 | -1% | -$51.3K |
|
20
Viking Therapeutics
VKTX
$3.04B
| $4.81M | 1.38% | 1,100,800 +620,242 | +129% | +$2.71M |
|
21
Ultragenyx Pharmaceutical
RARE
$2.89B
| $4.08M | 1.17% | 80,000 -10,000 | -11% | -$510K |
|
|
ACHN
22
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $4.06M | 1.16% | 1,095,100 +655,100 | +149% | +$2.43M |
|
|
23
Assertio
ASRT
$80.4M
| $3.95M | 1.13% | +600,000 | New | +$3.95M |
|
|
24
PTC Therapeutics
PTCT
$3.92B
| $3.92M | 1.12% | +145,000 | New | +$3.92M |
|
|
25
TG Therapeutics
TGTX
$4.65B
| $3.89M | 1.11% | +274,200 | New | +$3.89M |
|